Designing a vector system that works in hypoxic conditions by adding oxygen dependent degradation (ODD) domain to ptre / tet-off plasmid system and chacterization of the system in ischemic conditions
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
Tissue hypoxia, or ischemia, is the condition that describes the poor conveyance of oxygen and other vital products to tissues and organs. Ischemia progress silently, patients miss timely and proper treatments. In order to provide cardiovascular protection against ischemia and reperfusion, we are developing a vigilant gene therapy system whose expression level can be automatically up regulated by hypoxic ischemia. HIF-1α is a transcription factor that functions as a master regulator of oxygen homeostasis. HIF-1α protein levels increase under hypoxic conditions because of decreased O2 dependent prolyl-hydroxylation. ODD domain of HIF-1α was used as a switch to turn on the target gene expression in response to hypoxic signal. This hypoxia inducible plasmid system is a double plasmid system: transactivator plasmid and reporter plasmid. Chimeric transcription factor (TET-ODD) is being produced constantly from transactivator plasmid. In hypoxic condition, TET-ODD can stay stabilized in the cell and triggers expression of target gene. Our experiments showed that the ODD-mediated expression could quickly increase 4 fold within 6 hours of hypoxia (n=3) (p<0.05). Also, localization and stabilization of TET-ODD transcription factor was proved by immunofluorescence assay (IF) ad western blotting (WB) analysis. WB results showed that expression of TET-ODD protein increase 6-fold. The IF test showed that ODD linked tTA proteins were localized mainly in the cytoplasm. The ODD-TETR-VP16 protein showed high-ranking hydroxylation stability under hypoxia in protein modelling. From these results, we concluded that this hypoxia inducible double plasmid system could be used therapeutically to switch on genes that have proven beneficial effects in ischemia. Keywords: Gene Threapy, Hypoxia, Proline residue, Synthetic Biology, Transcription Factor
Author
Ayşe Çelik
How to Cite
Ayşe Çelik (Doctorate thesis). Designing a vector system that works in hypoxic conditions by adding oxygen dependent degradation (ODD) domain to ptre / tet-off plasmid system and chacterization of the system in ischemic conditions, 2018, Ankara Yıldırım Beyazıt University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Ankara Yıldırım Beyazıt University
- Investigation of family functionality detected by adolescents with peer bullying(2019)
- Urban life in Mosul according to the sâlnâmes (1308-1330/1891-1912)(2025)
- Obstacles of e-government development in Yemen(2022)
- Characteristics of patients with epilepsy admitted to the pediatric emergency service(2022)
- Trend networks of Twitter: Examining trends of Twitter Turkey through the concept of network society(2022)
- The impact of the Arab Spring on conflicts in the MENA region: Findings from count data analysis(2022)